Tag Archives: JPND

Alzheimer's & DementiaThe JPND working group on vascular contributions to neurodegeneration, which was selected under the 2014 call for working groups on cohort studies, brought together 55 international experts on brain disease and dementia to survey the data from more than 90 studies, representing more than 660,000 participants.

The working group’s final results and recommendations were recently published in the journal Alzheimer’s & Dementia. To access the full paper, “METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration,” click here.

Muscle & Nerve“A comparative study of peripheral nerve MRI and ultrasound in MMN and ALS” has been published in Muscle & Nerve. This research was supported in part by JPND through the STRENGTH project, selected for support in the 2012 risk factors call, and the SOPHIA project, selected for support in the 2011 biomarkers call.

ActaNeuropathologicaCommunications“Revisiting rodent models: Octodon degus as Alzheimer’s disease model?” has been published in Acta Neuropathologica Communications. This research was supported in part by JPND through the NeuroGem project, selected under the 2013 cross-disease analysis call, and the PROP-AD project, selected under the 2015 JPco-fuND call.

nature“The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6” has been published in Nature. This work was supported in part by JPND through the CureALS project and the REfrAME project, both selected under the 2015 JPco-fuND call.

Nature Reviews NeurologySupportive and symptomatic management of amyotrophic lateral sclerosis has been published in Nature Reviews Neurology. This work was supported in part by JPND through the ALS-CarE project, selected under the 2012 healthcare call.

Neurobiology of Disease“The choroid plexus in health and in disease: Dialogues into and out of the brain” has been published in Neurobiology of Disease. This research was supported in part by JPND through the NeuroGem project, selected under the 2013 cross-disease analysis call, and PROP-AD, selected under the 2015 JPco-fuND call.